Publications by authors named "Clive Harmer"

Claim this Profile
R
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Hakim-Moulay Dehbi, Ujjal Mallick, Jonathan Wadsley, Kate Newbold, Clive Harmer

Lancet Diabetes Endocrinol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetry-based treatment for Graves' disease.
Steve L Hyer, Brenda Pratt, Matthew Gray, Sarah Chittenden, Yong Du, Clive L Harmer

Nucl Med Commun· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer.
Liam Welsh, Ceri Powell, Brenda Pratt, Kevin Harrington, Chris Nutting, Clive Harmer

J Clin Endocrinol Metab· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.
Ujjal Mallick, Clive Harmer, Beng Yap, Jonathan Wadsley, Susan Clarke

N Engl J Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and late toxicity of radioiodine therapy: detection and management.
Steve L Hyer, Kate Newbold, Clive L Harmer

Endocr Pract· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid cancer is rare. Foreword.
Clive Harmer

Clin Oncol (R Coll Radiol)· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer.
Glenn D Flux, Masud Haq, Sarah J Chittenden, Susan Buckley, Cecilia Hindorf, Clive L Harmer

Eur J Nucl Med Mol Imaging· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis.
Prasad Dandekar, Clive Harmer, Yolanda Barbachano, Peter Rhys-Evans, Kevin Harrington

Int J Radiat Oncol Biol Phys· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid cancer causing obstruction of the great veins in the neck.
Steve L Hyer, Prasad Dandekar, Kate Newbold, Masud Haq, Kshama Wechalakar, Clive Harmer

World J Surg Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study.
Teresa Guerrero Urbano, Catharine H Clark, Vibeke N Hansen, Elizabeth J Adams, Elizabeth A Miles, Clive Harmer

Radiother Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine carcinoma arising in soft tissue: three case reports and literature review.
Steve L Hyer, Jonathan McAleese, Clive L Harmer

World J Surg Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review.
Allan Hackshaw, Clive Harmer, Ujjal Mallick, Masud Haq, Jayne A Franklyn

J Clin Endocrinol Metab· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged survival due to spontaneous regression and surgical excision of malignant mesothelioma.
John E Pilling, Andrew G Nicholson, Clive Harmer, Peter Goldstraw

Ann Thorac Surg· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report.
Furio Pacini, Martin Schlumberger, Clive Harmer, Gertrud G Berg, Ohad Cohen

Eur J Endocrinol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic thyroid carcinoma causing superior vena caval obstruction diagnosed on I-131 scan.
Kshama Wechalekar, Masud Haq, Clive Harmer, Gary Cook

Clin Nucl Med· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medullary and non-medullary thyroid cancer in a family.
Audrey Ardern-Jones, Roderick J Harvey, Philip Wilson, Anup K Sharma, Vicky Murday, Clive Harmer

Acta Oncol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid cancer: an overview.
Masud Haq, Clive Harmer

Nucl Med Commun· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of advanced differentiated thyroid carcinoma with high activity radioiodine therapy.
Masud S Haq, Ralph V McCready, Clive L Harmer

Nucl Med Commun· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic 131I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer.
Henry Taylor, Stephen Hyer, Louiza Vini, Brenda Pratt, Gary Cook, Clive Harmer

Eur J Endocrinol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene.
Athena Matakidou, Nancy Hamel, Sanjay Popat, Kiersten Henderson, Tania Kantemiroff, Clive Harmer

Carcinogenesis· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results in elderly patients with differentiated thyroid carcinoma.
Louiza Vini, Stephen L Hyer, Jennifer Marshall, Roger A'Hern, Clive Harmer

Cancer· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of thyroid cancer.
Louiza Vini, Clive Harmer

Lancet Oncol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testicular dose and fertility in men following I(131) therapy for thyroid cancer.
Stephen Hyer, Louiza Vini, Mary O'Connell, Brenda Pratt, Clive Harmer

Clin Endocrinol (Oxf)· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis